Page last updated: 2024-08-17

veratramine and Liver Neoplasms

veratramine has been researched along with Liver Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Gao, Y; Ji, Z; Xia, Y; Xie, F; Xu, P; Yin, L; Zheng, W	1

Other Studies

1 other study(ies) available for veratramine and Liver Neoplasms

Article	Year
Veratramine suppresses human HepG2 liver cancer cell growth in vitro and in vivo by inducing autophagic cell death. Oncology reports, 2020, Volume: 44, Issue:2 Topics: Animals; Autophagic Cell Death; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases; Veratrum Alkaloids; Xenograft Model Antitumor Assays	2020

Article

Year

Veratramine suppresses human HepG2 liver cancer cell growth in vitro and in vivo by inducing autophagic cell death.

Oncology reports, 2020, Volume: 44, Issue:2

Topics: Animals; Autophagic Cell Death; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases; Veratrum Alkaloids; Xenograft Model Antitumor Assays

2020